Peter Choyke, M.D., F.A.C.R.
Molecular Imaging Program
Chief, Senior Clinician
National Cancer Institute
Building 10, Room 1B40
9000 Rockville Pike
Bethesda, MD 20892
Phone: 301-402-8409
Fax: 301-402-3191
pchoyke@mail.nih.gov
Dr. Choyke obtained his M.D. from Jefferson Medical College and completed his residency in diagnostic radiology at Yale-New Haven Hospital. Following an imaging fellowship at the University of Pennsylvania, he joined the faculty of Georgetown University and soon thereafter the Diagnostic Radiology Department, Clinical Center, NIH. In June 2004, he started the Molecular Imaging Program within the Center for Cancer Research, NCI.
Dr. Choyke's Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with prostate cancer or solid tumors. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.
The quality of these videocasts is dependent on the speed of your Internet connection. Many videocasts are streamed directly to your computer by software on the NIH VideoCasting Web site. Others require that you have a standalone player installed on your computer to handle the streaming. If you do not have a standalone player installed or if you are having problems viewing the videocast, please visit http://videocast.nih.gov/faq/.
|
CC Grand Rounds: (1) Imaging of Localized Prostate Cancer: Prelude to Focal Therapy (2) Revisiting Old Targets and Exploring New Ones in Patients with Advanced Prostate Cancer Speaker(s): Peter Choyke, M.D., F.A.C.R., Chief, Molecular Imaging Program, NCI June 2, 2010 60 minutes http://videocast.nih.gov/Summary.asp?File=15933 |
|
Cancer Research Now: Molecular Imaging in Prostate Cancer (Rough Cut) Speaker(s): Peter Choyke, M.D., F.A.C.R., Program Director, Molecular Imaging Program, NCI October 19, 2010 4 minutes, 31 seconds http://bethesdatrials.cancer.gov/rss/videocastdetail.aspx?webcastid=10 |
Some of the resources above require the use of a standalone player: Download Free RealPlayer 
Back to Top
Clinical Trials Research
The goal of the Molecular Imaging Program is to develop and test targeted imaging agents for use in cancer patients. The MIP has a preclinical program in which new compounds are tested in vivo, a translational component in which compounds are introduced into the clinic and a clinical component in which larger trials are conducted.
Read more
 | Watch/Listen to Dr. Choyke's videocast/podcast |
